A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Director – Contracts & Pricing

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timePasadena, CA, USA$230k - $250k

About the Job

Requirements

  • A bachelor's degree in finance, economics, or accounting is required.
  • At least 10 years of experience in the biotech or pharmaceutical industry, including at least 5 years in Market Access, Contracts & Pricing, or related functions.
  • Extensive experience building, leading, and executing pricing and contracting strategies within the pharmaceutical or biotechnology industry.
  • Deep expertise in pricing and contracting analytics, including gross-to-net forecasting and modeling.
  • Proven experience developing contract proposals, including financial modeling, return-on-investment assessments, and evaluation of gross-to-net implications, along with demonstrated negotiation strategy capability.
  • Strong understanding of pharmaceutical contract administration systems and reporting across payer, provider, government, specialty pharmacy, and distribution channels.
  • Expert knowledge of pharmacy benefits; Medicare fee-for-service and Managed Care; Medicaid; and federal purchasing programs such as VA/DoD and 340B.
  • Subject-matter expertise in the Inflation Reduction Act, including financial risks and strategic opportunities for manufacturers.
  • Excellent verbal, written, and presentation skills, with the ability to translate complex concepts for diverse audiences.
  • Exceptional attention to detail, with the ability to work independently and collaboratively across cross-functional teams, external partners, and vendors.
  • Willingness to travel as needed to engage with customers.
  • Candidates must have current, valid authorization to work in the country where the role is located.

Responsibilities

  • Support the development and execution of pricing and contracting strategies for pre-launch and in-market brands, aligned with overarching commercial goals.
  • Lead the creation of clear, compelling business cases to secure approval for major contracting initiatives.
  • Continuously monitor market dynamics, policy changes, and competitor pricing to inform recommendations and maintain competitive advantage.
  • Collaborate cross-functionally with Legal, Sales, Finance, and other functions to refine pricing and contracting strategies and ensure optimal product commercialization and profitability.
  • Support the Payer Team during key customer engagements and negotiations, representing pricing and contracting as needed.
  • Provide pricing and reimbursement insights to help evaluate U.S. policy and legislative developments.
  • Partner with Finance to support quarterly close processes, including discount forecasting, gross-to-net analytics, and utilization by contract segment.
  • Drive continuous improvement and innovation in pricing and contracting processes, tools, and governance.
  • Ensure compliance with all federal, state, and company policies related to pricing, contracting, and market access activities.

Desired Qualifications

  • An advanced degree, such as an MBA or a master's degree in a related field.
  • Passion for science-driven storytelling and an interest in Arrowhead’s mission to advance RNA interference-based therapeutics.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs